• Email:
  • Password:
  • Remember Me
 
Lecture Hall Wound Care | Treatment

An Introduction to hyperbaric oxygen therapy

Available Credits
CPME 0.75

Jeffrey A. Niezgoda
Jeffrey A. Niezgoda, MD
Hyperbaric & Wound Care Associates
Milwaukee, WI
System Requirements Method of Participation Disclosure Information

Dr. Jeffrey A. Niezgoda introduces the listener to the topic of Hyperbaric Oxygen Therapy. The lecture begins with an overview of compromised wound healing and a detailed discussion of the critical role that oxygen plays in the healing cascade. Chronic wounds are stagnant between the inflammatory and proliferative phases, because of oxygen deficit. In the early injury phase of healing, the metabolic demands of tissue increase by a factor of 20 or more. Dr. Niezgoda explains the very significant role that oxygen plays in wound healing. All four wound healing phases are oxygen dependent. Collagen synthesis, which is so important in wound healing, will only occur with tissue oxygen tensions above 30mmHg. Oxygen promotes angiogenesis and is both bacteriostatic and bactericidal. Hyperbaric oxygen is a therapeutic mechanism in which the patient is placed in an enclosed chamber in which 100% oxygen is inhaled in a systemic pressurized environment. The patient's blood and hemoglobin become hyper saturated with O2, thereby affecting the stagnant wound in a positive way. Dr. Niezgoda details the physiology and mechanism of action of Hyperbaric Oxygen. The emergent indications such as carbon monoxide poisoning, decompression illness, and gas gangrene are reviewed. Routine indications such as osteomylelitis, compromised tissue flaps and grafts, and arterial insufficiency are also discussed. Contraindications, risks and benefits are presented. The large "aerospace like" multiplace chambers that come to mind when we think of decompression illness or gas embolism are no longer the norm.

Goal and Objective
After participating in this activity, the viewer should be better able to:
1. Describe what compromised wound healing is.
2. Explain the role of oxygen in wound healing.
3. Describe the definition and physiology of hyperbaric oxygen therapy.
4. Recognize the indications for hyperbaric oxygen therapy.

Estimated time to complete this activity is 49 minutes.

Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
PODIATRY: The Ohio College of Podiatric Medicine(OCPM) is an approved sponsor of Continuing Podiatric Medical Education through the Council on Podiatric Medical Education (CPME).

The Ohio College of Podiatric Medicine credits this activity for 0.75 credit hour.

Release Date: 01/01/2007 Expiration Date: 12/30/2012
Peer Review: on 01/01/2007

System Requirements
An Introduction to hyperbaric oxygen therapy
Top
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures. While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback. You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox, or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials. For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
Method of Participation
An Introduction to hyperbaric oxygen therapy
Top
Complete the 4 steps to earn CE/CME credit:
  • Complete and submit the required pre-test
  • View Lecture
  • Complete and submit post-test and program evaluation. Credit will be issued with a passing score of 70% or better.
  • Click Print Certificate.
Disclosure Information
An Introduction to hyperbaric oxygen therapy
Top
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
Jeffrey A. Niezgoda, MD has disclosed that he receives Grant/Research Support from KCI, King and Athenagen. He also receives Honorarium/Expenses, is a Consultant and member of the Speaker's Bureau for KCI.